Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
about
P1343
Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated propertiesEBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases.An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survivalEpstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationEpstein-Barr virus microRNAs are evolutionarily conserved and differentially expressedFrom Conventional to Next Generation Sequencing of Epstein-Barr Virus GenomesCo-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisSAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinomaReactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidineIdentification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial MalignanciesSalt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death.Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.Modeling nasopharyngeal carcinoma in three dimensionsIdentification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern ChineseMinicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesisEpigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinomaIn nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinomaMethylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinomaDown-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.Human tumor virus utilizes exosomes for intercellular communication.RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosisSequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98.Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinomaClinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.
P2860
Q24299572-AA1C8F94-E8A4-4446-AD19-78FAC150D30DQ24529069-A2AC1F8F-8146-4557-8D68-41FBF8D3028FQ24649032-F65A116D-3AE9-4A2A-BC90-A9A0B9BA7EDBQ24671870-0A2E4677-54E8-4E89-AEA0-5C349E9EC936Q25257225-39656E82-398B-497D-9B4B-EFC0E8F8DF67Q26765442-9FF229BC-8ACF-493D-9CCB-BA7A97792452Q28077209-387A4C82-BC2E-4F0A-8469-31028419E7B3Q28235586-2A5580F3-629B-4B40-B71B-44F5AC8B7818Q28537881-D81487A5-E19A-4F03-A357-B41FF1687E8BQ28551855-F81B8963-5A7B-4A28-BBBA-F29EAFC7EF48Q30577179-354135CC-23DE-4A5A-AE33-1879EEBAAC71Q33373662-FE974D66-2377-4874-8B61-DEC9C115B2ABQ33599243-FB556A89-966D-4530-A149-FDB72E0F441DQ33809442-168599C6-BA5D-4B79-A95F-DCC5A7DB6537Q33900865-C9041785-E969-4EEA-8C77-0C877F96D2ACQ33942005-62D63E97-139F-48CE-931D-F50EBA21F2E4Q34023389-C13748C0-5A4C-4ECB-950C-6AA5AF7787E9Q34050917-E0FE3BDA-86AA-4BB4-AD0D-665DEBC8D8B2Q34092709-C82B94A5-D2B1-4BFE-A867-9E84737E3259Q34120915-0A017752-A470-4D6E-BD87-1F23F2B30292Q34126659-E4297115-A5F6-4261-9C7C-C380AF5B84FBQ34173615-37561B88-E586-49B9-B5D0-9D703BB0C761Q34212911-8F091B15-F0DA-4845-BC2A-4FF2621F14EBQ34236524-81C694A4-08D1-49D2-80CE-0D5C6CA3D6B9Q34261764-E085E469-1ABC-4E8E-93F4-FFD011F89266Q34262286-056BEB17-C858-4E59-BB1B-AC109BFD0FFBQ34262322-2C7EE85A-A5FE-48C0-AA1B-8246CABA2C98Q34282719-473DBBCD-23BD-4AB0-A847-DE370CA73504Q34345591-58BA592E-F313-4F63-A19E-B5E5A249335CQ34365798-491541D7-3B84-4F49-A293-AD414227DC01Q34371119-AE09211F-479C-4DB3-943F-4D52EB00AC27Q34377767-F3043F65-DF94-40AB-9D8C-86D4A0D19B52Q34408248-B5127DCA-8C3E-4420-94E9-24A04F8C7527Q34410536-F220A37B-E5DA-4516-81AC-8EF94F75ED26Q34485302-CD9C4423-323F-4860-8AB5-3194DA20E31FQ34507851-1E5CC8A8-43DD-44E9-9798-2025CA284442Q34533871-1C47D750-37AB-48CB-8581-537FDEDC14FAQ34561758-8E428652-42A6-42EF-B92E-8FDACEB490B8Q34589178-2A89EC71-6553-4890-BDAB-C070C9471107Q34749417-E56D2CC0-0C77-482A-9646-BE9D471A8AD9
P2860
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
@en
type
label
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
@en
prefLabel
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
@en
P2093
P2860
P1476
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
@en
P2093
B M Whitney
S T Cheung
P2860
P304
P356
10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F
P4510
P577
1999-09-01T00:00:00Z